VACC insider filings

Vaccitech plc — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-28. Screen VACC transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for VACC between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Vaccitech plc

FiledFormInsiderReported transactionsSource
2023-06-284Scheeren Joseph — DirectorPurchase (P): 10,000 @ $2.44EDGAR
2023-06-014Wright Robin — DirectorPurchase (P): 13,750 @ $2.66EDGAR
2023-05-124Wright Robin — DirectorGrant/award (A): 19,197 (derivative) @ $0EDGAR
2023-05-124Scheeren Joseph — DirectorGrant/award (A): 19,197 (derivative) @ $0EDGAR
2023-05-124Morgon Pierre A. — DirectorGrant/award (A): 19,197 (derivative) @ $0EDGAR
2023-05-124Hammacher Alex — DirectorGrant/award (A): 19,197 (derivative) @ $0EDGAR
2023-05-124Phillips Anne M. — DirectorGrant/award (A): 19,197 (derivative) @ $0EDGAR
2023-05-124DAWES KAREN A — DirectorGrant/award (A): 19,197 (derivative) @ $0EDGAR
2023-03-294Marshall Margaret — Chief Medical OfficerGrant/award (A): 60,000 (derivative) @ $0EDGAR
2023-03-294Evans Thomas George — Fmr Chief Scientific OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2023-03-294Enright William — Chief Executive Officer, DirectorSale (S): 15,000 @ $2.42EDGAR
2023-02-244Pelletier Nadege — Chief Scientific OfficerGrant/award (A): 485,000 (derivative) @ $0EDGAR
2023-02-234Ellis Christopher — Chief Operating OfficerGrant/award (A): 105,000 (derivative) @ $0EDGAR
2023-02-234Griffiths Graham — Chief Business OfficerGrant/award (A): 105,000 (derivative) @ $0EDGAR
2023-02-234Brown Gemma — Chief Financial OfficerGrant/award (A): 33,100 (derivative) @ $0EDGAR
2023-02-234Enright William — Chief Executive Officer, DirectorGrant/award (A): 440,000 (derivative) @ $0EDGAR
2022-10-044M&G Alternatives Investment Management Ltd — 10% ownerOther (J): 4,108,752 @ $0EDGAR
2022-10-044M&G INVESTMENT MANAGEMENT LTD — 10% ownerOther (J): 4,108,752 @ $0EDGAR
2022-09-284Brown Gemma — Chief Financial OfficerGrant/award (A): 334,000 (derivative) @ $0EDGAR
2022-08-264Griffiths Graham — Chief Business OfficerSale (S): 10,000 @ $7.39EDGAR
2022-08-264Ellis Christopher — Chief Operating OfficerOption exercise (M): 450 @ $0.00 · Sale (S): 450 @ $4.78 · Option exercise (M): 39,176 @ $0.00 · Sale (S): 14,176 @ $5.69 · Sale (S): 25,000 @ $7.07 · Option exercise (M): 450 (derivative) @ $0 · +1 moreEDGAR
2022-08-194Ellis Christopher — Chief Operating OfficerOption exercise (M): 649 @ $0.00 · Sale (S): 649 @ $4.77 · Option exercise (M): 2,175 @ $0.00 · Sale (S): 2,175 @ $4.84 · Option exercise (M): 649 (derivative) @ $0 · Option exercise (M): 2,175 (derivative) @ $0EDGAR
2022-08-194Griffiths Graham — Chief Business OfficerSale (S): 500 @ $4.76EDGAR
2022-08-174Ellis Christopher — Chief Operating OfficerOption exercise (M): 5,350 @ $0.00 · Sale (S): 5,350 @ $4.76 · Option exercise (M): 2,200 @ $0.00 · Sale (S): 2,200 @ $4.78 · Option exercise (M): 5,350 (derivative) @ $0 · Option exercise (M): 2,200 (derivative) @ $0EDGAR
2022-08-174Griffiths Graham — Chief Business OfficerSale (S): 2,400 @ $4.75 · Sale (S): 1,220 @ $4.82EDGAR
2022-08-154Griffiths Graham — Chief Business OfficerSale (S): 5,000 @ $4.50EDGAR
2022-07-154Ellis Christopher — Chief Operating OfficerOption exercise (M): 5 @ $0.00 · Sale (S): 5 @ $6 · Option exercise (M): 5 (derivative) @ $0EDGAR
2022-07-154Griffiths Graham — Chief Business OfficerOption exercise (M): 1,931 @ $0.00 · Option exercise (M): 2,317 @ $0.00 · Option exercise (M): 3,090 @ $0.00 · Sale (S): 8 @ $5.28 · Code (L): 100 @ $5.87 · Option exercise (M): 1,931 (derivative) @ $0 · +2 moreEDGAR
2022-04-044Scheeren Joseph — DirectorPurchase (P): 10,000 @ $5.09EDGAR
2022-04-044Hammacher Alex — DirectorPurchase (P): 2,000 @ $5.14EDGAR
2022-02-114Marshall Margaret — Chief Medical OfficerGrant/award (A): 80,000 (derivative) @ $0EDGAR
2022-02-114Griffiths Graham — Chief Business OfficerGrant/award (A): 80,000 (derivative) @ $0EDGAR
2022-02-114Evans Thomas George — Chief Scientific OfficerGrant/award (A): 80,000 (derivative) @ $0EDGAR
2022-02-114Ellis Christopher — Chief Operating OfficerGrant/award (A): 80,000 (derivative) @ $0EDGAR
2022-02-114Egorov Georgy — Chief Financial OfficerGrant/award (A): 114,000 (derivative) @ $0EDGAR
2022-02-114Enright William — Chief Executive Officer, DirectorGrant/award (A): 359,605 (derivative) @ $0EDGAR
2022-01-044Hammacher Alex — DirectorPurchase (P): 1,000 @ $10.86EDGAR
2021-12-234Wright Robin — DirectorPurchase (P): 10,000 @ $9.97EDGAR
2021-05-074/AEnright William — Chief Executive Officer, DirectorGrant/award (A): 514,923EDGAR
2021-05-064Griffiths Graham — Chief Business OfficerPurchase (P): 100 @ $17EDGAR
2021-05-064Wright Robin — DirectorPurchase (P): 14,000 @ $17EDGAR
2021-05-064Ellis Christopher — Chief Operating OfficerPurchase (P): 75 @ $17EDGAR
2021-05-064Scheeren Joseph — DirectorPurchase (P): 3,000 @ $17EDGAR
2021-05-064Oxford Sciences Innovation plc — 10% ownerConversion (C): 4,832,142 · Conversion (C): 1,704,444 · Conversion (C): 1,661,184 · Purchase (P): 600,000 @ $17 · Conversion (C): 4,832,142 (derivative) · Conversion (C): 1,704,444 (derivative) · +1 moreEDGAR
2021-05-064Phillips Anne M. — DirectorPurchase (P): 3,000 @ $17EDGAR
2021-05-064DAWES KAREN A — DirectorPurchase (P): 1,700 @ $17EDGAR
2021-05-044Egorov Georgy — Chief Financial OfficerGrant/award (A): 6,918 (derivative) @ $0 · Grant/award (A): 149,865 (derivative) @ $0EDGAR
2021-05-044Enright William — Chief Executive Officer, DirectorGrant/award (A): 455,775 · Grant/award (A): 176,130 (derivative) @ $0EDGAR
2021-05-044Phillips Anne M. — DirectorGrant/award (A): 34,328 (derivative) @ $0EDGAR
2021-05-044DAWES KAREN A — DirectorGrant/award (A): 34,328 (derivative) @ $0EDGAR

Recent 8-K events — Vaccitech plc

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-09-098-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-018-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
EDGAR
2026-08-258-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-028-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
2026-05-218-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-04-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-228-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-318-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-138-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VACC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs